Global Drug Delivery Systems Market Growth:
The global drug delivery systems market shall register an upswing, expanding at a strong CAGR of 7.0% during the forecast period (2020-2025). Rising incidences of severe chronic and infectious diseases over the past five decades has boosted demand for drug development. The WHO estimates that over 70 million individuals have been infected by deadly diseases such as HIV. Such trends have naturally pushed healthcare practitioners to develop enhanced drugs and their delivery systems.
The ongoing COVID-19 pandemic shall heighten prospects of drug delivery systems. As the number of infections increase exponentially every day, hospitals and clinics are facing extreme shortages of essential medical equipment such as respirators and ventilators. To address this shortage, leading pharmaceutical and healthcare companies have accelerated production of essential drug delivery systems. The easing of lockdowns and social distancing measures is expected to restore production cycles to a significant extent, leading to better output and addressing acute shortfalls in the supply of drug delivery devices and systems.
Global Drug Delivery Systems Market: Technological Insights:
Several advancements have been made in the field of drug delivery systems. The most significant of them is the incorporation of three-dimensional printing (3D-printing). 3D-printing is a unique prototyping drug delivery technology. It can easily overcome problems associated with the delivery of less water soluble potent drugs, peptides and multi-drugs. The technology can produce solid dosage forms with multiple drugs and excipients, complex internal geometries, variable diffusivities and densities. Similarly, electronic drug delivery drug systems are gaining huge traction in the market.
Global Drug Delivery Systems Market: Delivery Type Insights:
The targeted drug delivery type is expected to be the dominant segment, capturing nearly half of the global drug delivery systems market, expanding at a healthy CAGR of 6.8% across the forecast period. Application of nanotechnology is a key growth determinant for the segment. Insertion of nanoparticles helps penetrate the targeted tissue in a much better manner. These particles are easily absorbed by cells, facilitating efficient drug delivery. Another popular technique is that of microneedle drug delivery.
The polymeric drug delivery segment is anticipated to be the second-most lucrative, expanding at a CAGR of 7.3% across the forecast period. The popularity of this delivery type is attributed to its efficiency in localized drug delivery in large amounts. Polymeric drug delivery is especially helpful in treating chronic conditions such as cancer, especially solid tumors. It also has a lower toxicity rate. The polymeric drug delivery segment shall capture more than 1/3rd of the global drug delivery systems market during the forecast period.
To know more about the drug delivery systems market, ask an analyst here
Global Drug Delivery Systems Market: Application Insights:
In terms of application, the oncology segment shall expand the fastest, at a CAGR of 7.5%, accounting for a market share of more than 1/4th. The CNS segment is the second-most lucrative, capturing more than one-fifth of the global drug delivery systems market and expanding at a rate of 6.9%.
Increasing prevalence of cancers such as leukemia, brain tumor, colon cancer, stomach cancer, etc., have boosted the demand for advanced drug delivery systems in the oncology segment. Increase in demand for advanced medication for several neurological disorders such as dementia, epilepsy and neuroinfections is expected to boost the CNS segment.
Global Drug Delivery Systems Market: Regional Insights:
North America dominated the global drug delivery systems market in 2016, accounting for almost two-fifths of the market share. This trend is expected to continue throughout the forecast period, retaining the same market share and expanding at a CAGR of 6.8%. However, Asia-Pacific shall present credible growth opportunities, growing at the rate of 7.8% across the forecast period and accounting for more than 1/5th of the global drug delivery systems market.
Increased prevalence of chronic diseases, government efforts to spread awareness about such diseases, increased research and development operations and introduction of advanced drug delivery technologies shall augment the North American market. Prevalence of acute disease such as tuberculosis and pneumonia in countries such as India and China along with favorable reimbursement policies for leading drug delivery manufacturers shall drive growth in the Asia-Pacific region.
To get the latest COVID-19 impact insights on the drug delivery systems market, request for a report sample here
Global Drug Delivery Systems Market Manufacturers
The existing global drug delivery systems market is highly competitive, attributed to the presence of multiple local as well as global manufacturers of drug delivery products. The market is characterized by extensive research efforts and technological advancements. Investment in R&D to develop new grade drug delivery products and addressing complications, concerns and side-effects of their usage characterize the intense rivalry amongst market players. Some prominent manufacturers in the market include, but are not limited to, Boston Scientific Corporation, Johnson and Johnson Services, Inc., Pfizer, Inc., Baxter International, Inc., Amgen, Inc., Novartis AG, F. Hoffmann La-Roche Ltd., and Bayer AG.
Novartis AG recently acquired a patent in February 2020 for the development of thermogelling peptide delivery systems which are injected as fluid sol at ambient temperature via an injection. The company also manufactures the ZYKADIA for the treatment of non-small lung cancer. The company also manufactures Binocrit, a medicine to treat symptomatic anemia associated with chronic renal failure among adults as well as pediatric patients. Pfizer, Inc., another prominent market player, provides the iSecure, ABBOJECT and CARPUJECT syringe systems. Additionally, it also offers IV drug delivery systems such as the ADD-Vantage ADDaptor delivery system.
COVID-19’s Impact on the Global Drug Delivery Systems Market:
The scope of the global drug delivery systems market is expected to leverage amidst the COVID-19 pandemic. As the rate of infection is accelerating rapidly on a daily basis, hospitals need to accommodate the ever-increasing number of patients. This has resulted in a demand-supply gap, with regard to the availability of important medical delivery systems like respirators and inhalers to the patients.
Fortunately, leading market players are accelerating the production of these devices and minimizing the disruptions in the demand-supply equation. The recent easing of lockdowns in countries such as India have enabled manufacturers to restore their production capacities to a very large extent. This factor is poised to address any shortfalls which may have occurred in the past several weeks. Consequently, production of respirators and inhalers shall increase, enabling healthcare providers to accommodate more patients.
Besides, delivery system techniques such as emulsions are being heavily tested as a possible approach towards the eradication of the coronavirus. It is believed that emulsification-based drug delivery systems reduce water compounds, an ideal condition for viruses to survive. The technique is not without limitations, however, and healthcare practitioners are doing their best to address these limitations.
Moreover, key market players such as Novartis AG are responding efficiently to the pandemic. The company has recently announced plans to initiate a Phase III clinical trial to study the effects of the canakinumab monoclonal antibody in patients with COVID-19 pneumonia. Likewise, Pfizer, Inc., has put together a team of leading virologists, biologists, chemists, clinicians, epidemiologists and vaccine experts to accelerate the development of its COVID-19 mRNA vaccine program, BNT162.
“The global drug delivery systems market has a promising future ahead, on the back of rising incorporation of technological advancements. Moreover, the COVID-19 pandemic has accelerated research and development of new drug delivery systems to inhibit the proliferation of the novel coronavirus strains in the human body
Global Drug Delivery Systems Market: Report Scope:
The recent study on the global drug delivery systems market by Fact.MR provides a 5-year forecast, ranging from 2020 to 2025, on the key drivers, opportunities and restraints impacting the market. A detailed analysis has been conducted, considering each segment’s market share, revenue and possible growth across the forecast period. The segmentation is done based on drug delivery systems, type, route of administration and application.
In addition, a regional landscape detailing the analysis of the abovementioned segments across five geographies (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) has been incorporated. The final section of the report includes a competition landscape, which details key companies’ revenue and market shares, future growth prospects, key mergers and acquisitions and product launches. A SWOT analysis of each players has also been provided in order to present a realistic picture for future growth.
Global Drug Delivery Systems Market- Scope of the Report
The recent study by Fact.MR on the global drug delivery systems market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global drug delivery systems market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the production of drug delivery systems. The study also provides dynamics responsible for influencing the future status of the drug delivery systems market over the forecast period.
A detailed assessment of the global drug delivery systems market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global drug delivery systems market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Drug Delivery Systems Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global drug delivery systems markets across the globe.
A comprehensive estimate of the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales in the global drug delivery systems market during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Drug Delivery Systems: Market Segmentation
Fact.MR has studied the global drug delivery systems market with detailed segmentation on the basis of delivery system, route of administration, application and region.
Route of Administration
Intra Uterine Implants
Polymeric Drug Delivery
Targeted Drug Delivery
Middle East & Africa (MEA)
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Global Drug Delivery Systems Market: Analysis on Market Size Evaluation
The global drug delivery systems market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for global drug delivery systems is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global drug delivery systems market segments, along with market attractiveness evaluation, has been incorporated in the report.
Global Drug Delivery Systems Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global drug delivery systems report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global drug delivery systems market during the forecast period.
Country-specific valuation on demand for global drug delivery systems has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
Global Drug Delivery Systems Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading providers of global drug delivery systems along with their detailed profiles. Essential and up-to-date data information related to market performers, who are principally engaged in the production of drug delivery systems, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis of each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global drug delivery systems market. Prominent manufacturers with established market presence in global drug delivery systems market are Boston Scientific Corporation, Johnson and Johnson Services, Inc., Pfizer, Inc., Baxter International, Inc., Amgen, Inc., Novartis AG, F. Hoffmann La-Roche Ltd., and Bayer AG among others.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug Delivery Systems Market
4. Market Overview
4.1.1. Product Overview
4.1.2. Industry Evolution / Developments
4.2. Market Dynamics
4.3. Pipeline Analysis – Drug Therapy Products
4.4. Porter’s Five Force Analysis
4.5. Technological Advancement in Drug Delivery Products
4.6. Regulatory Scenario
4.7. Key Mergers and Acquisitions
4.8. Global Drug Delivery Systems Market Analysis and Forecasts, 2015-2025
4.8.1. Market Revenue Projection (US$ Mn)
4.8.2. Market Outlook
5. Global Drug Delivery Systems Market Analysis and Forecasts, By Delivery Systems
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Delivery Systems, 2020–2025
5.3.1. Intrauterine Implants
5.3.2. Prodrug Implants
5.3.3. Polymeric Drug Delivery
5.3.4. Targeted Drug Delivery
5.4. Market Attractiveness By Delivery Systems
6. Global Drug Delivery Systems Market Analysis and Forecasts, By Application
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast By Application, 2020–2025
6.3.1. Infectious Disease
6.4. Market Attractiveness By application
7. Global Drug Delivery Systems Market Analysis and Forecasts, By Route of Administration
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast By Route of Administration, 2020–2025
7.4. Market Attractiveness By Route of Administration
8. Global Drug Delivery Systems Market Analysis and Forecasts, By Geography/Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast By Region
8.2.1. North America
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East and Africa
8.3. Market Attractiveness By Region
9. North America Drug Delivery Systems Market Analysis and Forecast
9.1. Market Value Forecast By Country, 2020–2025
9.2. Market Value Forecast By Delivery Systems, 2020–2025
9.3. Market Value Forecast By Application, 2020–2025
9.4. Market Value Forecast By Route of Administration, 2020–2025
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Delivery Systems
9.5.3. By Application
9.5.4. By Route of Administration
10. Europe Drug Delivery Systems Market Analysis and Forecast
10.1. Market Value Forecast By Country , 2020–2025
10.1.6. Rest of Europe
10.2. Market Value Forecast By Delivery Systems, 2020–2025
10.3. Market Value Forecast By Application, 2020–2025
10.4. Market Value Forecast By Route of Administration, 2020–2025
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Delivery Systems
10.5.3. By Application
10.5.4. By Route of Administration
11. Asia Pacific Drug Delivery Systems Market Analysis and Forecast
11.1. Market Value Forecast By Country , 2020–2025
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast By Delivery Systems, 2020–2025
11.3. Market Value Forecast By Application, 2020–2025
11.4. Market Value Forecast By Route of Administration, 2020–2025
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Delivery Systems
11.5.3. By Application
11.5.4. By Route of Administration
12. Latin America Drug Delivery Systems Market Analysis and Forecast
12.1. Market Value Forecast By Country, 2020–2025
12.1.3. Rest of LATAM
12.2. Market Value Forecast By Delivery Systems, 2020–2025
12.3. Market Value Forecast By Application, 2020–2025
12.4. Market Value Forecast By Route of Administration, 2020–2025
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Delivery Systems
12.5.3. By Application
12.5.4. By Route of Administration
13. Middle East and Africa Drug Delivery Systems Market Analysis and Forecast
13.1. Market Value Forecast By Country, 2020–2025
13.1.1. GCC Countries
13.1.2. South Africa
13.1.4. Rest of MEA
13.2. Market Value Forecast By Delivery Systems, 2020–2025
13.3. Market Value Forecast By Application, 2020–2025
13.4. Market Value Forecast By Route of Administration, 2020–2025
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Delivery Systems
13.5.3. By Application
13.5.4. By Route of Administration
14. Competition Landscape
14.1. Competition Matrix
14.1.1. Novartis AG
14.1.2. Amgen Inc.
14.1.3. F. Hoffmann-La Roche Ltd.
14.1.4. Pfizer Inc.
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. Novartis AG (HQ, Business Segments, Employee Strength)
126.96.36.199. Company Details
188.8.131.52. Company Description
184.108.40.206. Business Overview
220.127.116.11. SWOT Analysis
18.104.22.168. Financial Analysis
22.214.171.124. Strategic Overview
14.2.2. Amgen Inc. (HQ, Business Segments, Employee Strength)
126.96.36.199. Company Details
188.8.131.52. Company Description
184.108.40.206. Business Overview
220.127.116.11. SWOT Analysis
18.104.22.168. Strategic Overview
14.2.3. F.Hoffmann-La Roche Ltd. (HQ, Business Segments, Employee Strength)
22.214.171.124. Company Details
126.96.36.199. Company Description
188.8.131.52. Business Overview
184.108.40.206. SWOT Analysis
220.127.116.11. Strategic Overview
14.2.4. Pfizer Inc. (HQ, Business Segments, Employee Strength)
18.104.22.168. Company Details
22.214.171.124. Company Description
126.96.36.199. Business Overview
188.8.131.52. SWOT Analysis
184.108.40.206. Strategic Overview
14.2.5. Johnson & Johnson Services, ltd. (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Details
18.104.22.168. Company Description
22.214.171.124. Business Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Financial Analysis
184.108.40.206. Strategic Overview
14.2.6. Becton, Dickinson and Company (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Details
18.104.22.168. Company Description
22.214.171.124. Business Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Financial Analysis
184.108.40.206. Strategic Overview
14.2.7. AstraZeneca plc (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Details
18.104.22.168. Company Description
22.214.171.124. Business Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Financial Analysis
184.108.40.206. Strategic Overview
14.2.8. Baxter International, Inc. (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Details
18.104.22.168. Company Description
22.214.171.124. Business Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Financial Analysis
184.108.40.206. Strategic Overview
14.2.9. Bayer AG (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Details
18.104.22.168. Company Description
22.214.171.124. Business Overview
126.96.36.199. SWOT Analysis
188.8.131.52. Strategic Overview
14.2.10. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
184.108.40.206. Company Details
220.127.116.11. Company Description
18.104.22.168. Business Overview
22.214.171.124. SWOT Analysis
126.96.36.199. Strategic Overview
Fact.MR offers custom research services that help clients to get specific research solutions